1-6 of 6
Michael D Pickard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sequence analysis of β-subunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasone

Brief Report
David I. Lichter, Hadi Danaee, Michael D. Pickard, Olga Tayber, Michael Sintchak, Hongliang Shi, Paul G. Richardson, Jamie Cavenagh, Joan Bladé, Thierry Façon, Ruben Niesvizky, Melissa Alsina, William Dalton, Pieter Sonneveld, Sagar Lonial, Helgi van de Velde, Deborah Ricci, Dixie-Lee Esseltine, William L. Trepicchio, George Mulligan, Kenneth C. Anderson
Journal: Blood
Blood (2012) 120 (23): 4513–4516.
https://doi.org/10.1182/blood-2012-05-426924
Published: 2012
Includes: Supplemental data
Journal Articles

The Novel, Investigational NEDD8-Activating Enzyme Inhibitor MLN4924 In Adult Patients with Acute Myeloid Leukemia (AML) or High-Grade Myelodysplastic Syndromes (MDS): A Phase 1 Study

Ronan T Swords, MD, MRCPI, FRCPath, Harry P Erba, MD, PhD, Daniel J DeAngelo, MD, PhD, Peter G Smith, PhD, Michael D Pickard, MA, Bruce J. Dezube, MD, Francis J. Giles, MB, MD, FRCPI, FRCPath, Bruno C. Medeiros, MD
Journal: Blood
Blood (2010) 116 (21): 658.
https://doi.org/10.1182/blood.V116.21.658.658
Published: 2010
Journal Articles

Phase 1 Dose-Escalation Study of Multiple Dosing Schedules of the Investigational Drug MLN4924, a Nedd8-Activating Enzyme Inhibitor, In Patients with Relapsed and/or Refractory Multiple Myeloma or Lymphoma.

Jatin J Shah, MD, R. Donald Harvey, PharmD, Owen A O'Connor, MD, PhD, Andrzej J Jakubowiak, MD, PhD, Mitchell R Smith, MD, PhD, Robert Z. Orlowski, MD, PhD, George J Mulligan, PhD, Peter G Smith, PhD, Michael D Pickard, MA, Bruce J. Dezube, MD, Sagar Lonial, MD
Journal: Blood
Blood (2010) 116 (21): 2801.
https://doi.org/10.1182/blood.V116.21.2801.2801
Published: 2010
Journal Articles

The Novel Proteasome Inhibitor MLN9708 Demonstrates Efficacy in a Genetically-Engineered Mouse Model of DeNovo Plasma Cell Malignancy.

Siegfried Janz, Brian G Van Ness, Vishala Neppalli, Ray Liu, Michael D Pickard, Jennifer Terkelsen, Daniel Bradley, Ling Hu, Erik Kupperman, Mark Manfredi, Edmund Lee
Journal: Blood
Blood (2009) 114 (22): 3849.
https://doi.org/10.1182/blood.V114.22.3849.3849
Published: 2009
Journal Articles

Phase 1 Dose-Escalation Study of MLN4924, a Novel NAE Inhibitor, in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma.

Jatin J Shah, Andrzej J Jakubowiak, Owen A O’Connor, Robert Z Orlowski, Molly Patterson, Donald Harvey, Allison J Berger, Alice McDonald, George Mulligan, Lilli Petruzzelli, Michael D Pickard, Peter G Smith, Karthik Venkatakrishnan, Sagar Lonial
Journal: Blood
Blood (2009) 114 (22): 1854.
https://doi.org/10.1182/blood.V114.22.1854.1854
Published: 2009
Journal Articles

Immunohistochemical Analyses for Potential Biomarkers of Bortezomib Activity in Mantle Cell Lymphoma from the PINNACLE Phase 2 Trial.

Andre Goy, Steven H. Bernstein, Alice McDonald, Michael D. Pickard, Mark D. Fleming, Barb Bryant, William Trepicchio, Richard I. Fisher, Anthony Boral, George Mulligan
Journal: Blood
Blood (2007) 110 (11): 2573.
https://doi.org/10.1182/blood.V110.11.2573.2573
Published: 2007